Bryan Pine

Bryan Pine consults on economic issues arising in mergers and in antitrust and competition litigation, with a focus on the healthcare industry. Mr. Pine leads teams and manages research processes for matters involving massive volumes of data, including those related to hospital systems and technology companies. He has consulted on matters in the U.S., UK, and Australia.

Merger reviews and litigation

Mr. Pine has experience supporting clients before, during, and after the second request phase, including with risk assessment, data production, and presentations to the reviewing agencies. He has worked on behalf of both merging parties and the Department of Justice (DOJ). His representative experience includes:

• Assisting with data production to analyze competitive implications in First Advantage/Sterling Check
• Leading a large research team to analyze issues of market definition and alleged harm to consumers in American Airlines/JetBlue
• Analyzing competitive implications in Cigna’s acquisition of Express Scripts

Mr. Pine contributed analysis to T-Mobile/Sprint, AT&T’s purchase of Time Warner, and the proposed Aetna/Humana merger. He also analyzed insurance claims data in a matter involving the merger of two local hospitals, which was approved by the West Virginia Health Care Authority.

Antitrust and competition

Mr. Pine analyzes economic issues at the class certification stage in antitrust and competition matters, focusing on large hospital systems and physician networks. He has consulted on market definition, quality effects, price effects, and allegations of price fixing. His experience includes: 

• Evaluating the reliability of proposed damages models to assess alleged monopolistic behavior in digital content distribution and payments markets

Evaluating claims data, market definition, and allegations of tying in Sidibe et al. v. Sutter Health